Inflammatory diseases such as Crohn’s disease and multiple sclerosis have been linked to faults in a critical immune pathway that enables inflammation to continue unchecked. Researchers have shed new light on how this immune response is controlled, and hope it could lead to new drugs for people with these chronic diseases.